Disease-modifying therapies enter the World Health Organization Essential Medicines List: A victory now requiring a roadmap of implementation

Mult Scler. 2024 Jan;30(1):3-6. doi: 10.1177/13524585231205970. Epub 2023 Oct 18.

Authors

Bassem I Yamout¹, Shanthi Viswanathan², Joanna Laurson-Doube³, Dilraj Sokhi⁴

Affiliations

¹ Neurology Institute, Harley Street Medical Centre, Abu Dhabi, United Arab Emirates.
² Neurology Department, Kuala Lumpur Hospital, Kuala Lumpur, Malaysia.
³ Multiple Sclerosis International Federation, London, UK.
⁴ Aga Khan University Medical College in East Africa, Nairobi, Kenya.

PMID: 37850437
DOI: 10.1177/13524585231205970

No abstract available

Publication types

Editorial

MeSH terms

Drugs, Essential*
Humans
World Health Organization

Substances

Drugs, Essential